$339.1M in CY2024 Part D spend9.6M claims · 2.1M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Memantine used for?
Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Is there a generic for Memantine?
Yes. 70 ANDAs filed at FDA, 24 generic manufacturers currently shipping.
How much does my plan pay for Memantine?
Across 329 Part D plans, Memantine averages $0.063/unit (NADAC). Lowest available: $0.063/unit. Highest in distribution: $0.063/unit.
Is Memantine on the FDA shortage list?
Memantine has been discontinued by its manufacturer(s).
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.